AAAAAA

   
Results: 1-10 |
Results: 10
DEVELOPING MULTIPLE-SCLEROSIS PRACTICE GUIDELINES - THE MULTIPLE-SCLEROSIS COUNCIL FOR CLINICAL-PRACTICE GUIDELINES
Authors: MILLER DM SHINDELL S LUBLIN F
Citation: Dm. Miller et al., DEVELOPING MULTIPLE-SCLEROSIS PRACTICE GUIDELINES - THE MULTIPLE-SCLEROSIS COUNCIL FOR CLINICAL-PRACTICE GUIDELINES, Annals of neurology, 44(3), 1998, pp. 26-26
RECOMMENDATIONS FROM THE NATIONAL MULTIPLE-SCLEROSIS SOCIETY CLINICALOUTCOMES ASSESSMENT TASK-FORCE
Authors: RUDICK R ANTEL J CONFAVREUX C CUTTER G ELLISON G FISCHER J LUBLIN F MILLER A PETKAU J RAO S REINGOLD S SYNDULKO K THOMPSON A WALLENBERG J WEINSHENKER B WILLOUGHBY E
Citation: R. Rudick et al., RECOMMENDATIONS FROM THE NATIONAL MULTIPLE-SCLEROSIS SOCIETY CLINICALOUTCOMES ASSESSMENT TASK-FORCE, Annals of neurology, 42(3), 1997, pp. 379-382
INFLUENZA IMMUNIZATION IN MULTIPLE-SCLEROSIS - REPLY
Authors: MILLER A MORGANTE L BUCHWALD L NUTILE S COYLE P KRUPP L DOSCHER C LUBLIN F KNOBLER R TRANTAS F KELLEY L SMITH C LAROCCA N LOPEZ S
Citation: A. Miller et al., INFLUENZA IMMUNIZATION IN MULTIPLE-SCLEROSIS - REPLY, Neurology, 49(5), 1997, pp. 1475-1475
TREATMENT OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - REPLY
Authors: SIBLEY WA EBERS GC LUBLIN F PATY D REDER A
Citation: Wa. Sibley et al., TREATMENT OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - REPLY, Neurology, 49(2), 1997, pp. 641-642
CLINICAL OUTCOMES ASSESSMENT IN MULTIPLE-SCLEROSIS
Authors: RUDICK R ANTEL J CONFAVREUX C CUTTER G ELLISON G FISCHER J LUBLIN F MILLER A PETKAU J RAO S REINGOLD S SYNDULKO K THOMPSON A WALLENBERG J WEINSHENKER B WILLOUGHBY E
Citation: R. Rudick et al., CLINICAL OUTCOMES ASSESSMENT IN MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 469-479
NEUTRALIZING ANTIBODIES DURING TREATMENT OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - EXPERIENCE DURING THE FIRST 3 YEARS
Authors: DUQUETTE P GIRARD M DUBOIS R KOBLER RL LUBLIN F KELLEY L FRANCIS GS FREEDMAN M GREENSTEIN JI MISHRA B DELILLIO N WHITAKER J LAYTON B SIBLEY WA LAGUNA J KRIKAWA J PATY DW OGER JJ KASTRUKOFF LF MORRISON W NELSON J GOODIN D MASSA SM GUTTERIDGE E ARNASON BGW NORONHA A REDER AT MARTIA R EBERS GC RICE GPA LESAUX J JOHNSON KP PANITCH HS BEVER CT CONWAY K LI DKB TANTON EL ZHAO GJ FLAK B RIDDEBOUGH A COVER K RHODES B COOK A SMITH K COSTLEY L RENNEBERG S SHAW T GENTON M VANDENNOORT S WEINSHENKER B WEISS W REINGOLD S TAYLOR W WALLENBERG JC BEDELL L SIBLEY WA EBERS GC LUBLIN FD PATY DW REDER AT
Citation: P. Duquette et al., NEUTRALIZING ANTIBODIES DURING TREATMENT OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - EXPERIENCE DURING THE FIRST 3 YEARS, Neurology, 47(4), 1996, pp. 889-894
IFNB IN MS - REPLY
Authors: SIBLEY WA PATY D EBERS G REDER A LUBLIN F
Citation: Wa. Sibley et al., IFNB IN MS - REPLY, Neurology, 47(4), 1996, pp. 1112-1112
TISSUE SEGMENTATION AND VOLUMETRIC MEASUREMENTS AS A MARKER OF DISEASE-ACTIVITY IN MS
Authors: GONZALEZ CF VINITSKI S LUBLIN F KNOBLER R SHEHAGIRI S
Citation: Cf. Gonzalez et al., TISSUE SEGMENTATION AND VOLUMETRIC MEASUREMENTS AS A MARKER OF DISEASE-ACTIVITY IN MS, Neurology, 45(4), 1995, pp. 232-232
X-LINKED PURE FAMILIAL SPASTIC PARAPARESIS - CHARACTERIZATION OF A LARGE KINDRED WITH MAGNETIC-RESONANCE-IMAGING STUDIES
Authors: CAMBI F TARTAGLINO L LUBLIN F MCCARREN D
Citation: F. Cambi et al., X-LINKED PURE FAMILIAL SPASTIC PARAPARESIS - CHARACTERIZATION OF A LARGE KINDRED WITH MAGNETIC-RESONANCE-IMAGING STUDIES, Archives of neurology, 52(7), 1995, pp. 665-669
MS COSTAR - A COMPUTERIZED PATIENT RECORD ADAPTED FOR CLINICAL RESEARCH PURPOSES
Authors: PATY D STUDNEY D REDEKOP K LUBLIN F
Citation: D. Paty et al., MS COSTAR - A COMPUTERIZED PATIENT RECORD ADAPTED FOR CLINICAL RESEARCH PURPOSES, Annals of neurology, 36, 1994, pp. 190000134-190000135
Risultati: 1-10 |